Asian shares are lower after choppy trading on Wall Street that saw more losses as investors assess President Donald Trump's ...

Latham leaders said they had their eyes on recruiting David Marriott for “several years,” particularly after working ...

In an en banc petition filed this month before the U.S. Court of Appeals for the Ninth Circuit, Takeda Pharmaceutical and Eli Lilly sought rehearing of a June 16 decision upholding certification of a ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, while showing greater weight loss and blood sugar control.

New research results reported at the Alzheimer's Association International Conference® 2025 (AAIC®) advanced scientific understanding of ...

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk on Tuesday cut its full-year sales and operating profit forecasts for ...

Investors are awaiting the Federal Reserve's interest rate announcement Wednesday afternoon. Fed funds futures are pricing in ...

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival ...

High levels of a hormone found in cells in the gut could underlie many cases of chronic diarrhea and help explain up to 40% ...

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

Shares in the $247 bln obesity drugmaker fell over 20% after it said sales would grow more slowly than expected. Competition ...